29,563 Shares in Core Scientific, Inc. $CORZ Purchased by Fieldview Capital Management LLC

Fieldview Capital Management LLC bought a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 29,563 shares of the company’s stock, valued at approximately $430,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Xponance LLC grew its holdings in Core Scientific by 2.5% during the fourth quarter. Xponance LLC now owns 22,896 shares of the company’s stock worth $333,000 after acquiring an additional 562 shares during the period. Xponance Inc. grew its holdings in Core Scientific by 2.7% during the third quarter. Xponance Inc. now owns 22,334 shares of the company’s stock worth $401,000 after acquiring an additional 595 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Core Scientific by 3.5% during the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 21,029 shares of the company’s stock worth $377,000 after acquiring an additional 711 shares during the period. CWA Asset Management Group LLC grew its holdings in Core Scientific by 0.3% during the fourth quarter. CWA Asset Management Group LLC now owns 239,937 shares of the company’s stock worth $3,493,000 after acquiring an additional 756 shares during the period. Finally, Orion Porfolio Solutions LLC grew its holdings in Core Scientific by 5.2% during the third quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock worth $279,000 after acquiring an additional 766 shares during the period.

Insider Transactions at Core Scientific

In other news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $26.85, for a total transaction of $268,500.00. Following the completion of the sale, the insider owned 2,068,895 shares of the company’s stock, valued at $55,549,830.75. This represents a 0.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders have sold 70,000 shares of company stock worth $1,464,400. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

CORZ has been the topic of several analyst reports. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $32.00 target price on shares of Core Scientific in a report on Wednesday, June 3rd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a report on Monday, April 20th. HC Wainwright reissued a “buy” rating and issued a $25.00 price objective on shares of Core Scientific in a report on Tuesday, March 3rd. Wall Street Zen raised Core Scientific to a “sell” rating in a report on Saturday, March 14th. Finally, Needham & Company LLC raised their price objective on Core Scientific from $23.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Core Scientific has a consensus rating of “Moderate Buy” and an average target price of $29.49.

Core Scientific Trading Up 2.2%

Shares of CORZ opened at $28.22 on Tuesday. Core Scientific, Inc. has a 12 month low of $10.93 and a 12 month high of $30.46. The stock’s 50 day moving average is $23.01 and its two-hundred day moving average is $18.93. The firm has a market cap of $8.97 billion, a P/E ratio of -24.75 and a beta of 5.49.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Wednesday, May 6th. The company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The business had revenue of $115.24 million during the quarter, compared to the consensus estimate of $117.04 million. During the same quarter in the prior year, the firm posted $1.25 earnings per share. The company’s revenue for the quarter was up 44.9% compared to the same quarter last year. Equities research analysts forecast that Core Scientific, Inc. will post 0.08 EPS for the current year.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.